Hi Sabine, always a good sign when you start researching. A lot of things are uncovered...
I have a question. It appears they only needed 108 patients in a randomised phase and 75 in a single arm phase to meet the FDAs requirements for approval. This seems awfully low. Is that your understanding? I am interested for my research on another share and would be over the moon if that is it.
Hi Sabine, always a good sign when you start researching. A lot...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.025(2.33%) |
Mkt cap ! $338.9M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.10 | $10.20K | 9.298K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22000 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 26308 | 3 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| EBR (ASX) Chart |